First EIB loan under InnovFin in Greece: EUR 25 million for PHARMATHEN’s RDI activities
First EIB loan under InnovFin in Greece: EUR 25 million for PHARMATHEN’s RDI activities
Mr Vassilios Katsos, CEO Pharmathen S.A and EIB Director of New Products and Special Transactions, Mr Nicholas Jennett
Display original